Sponsored Links

REALISTIC: Certzolimab Delivers In Real World Situations PDF Print E-mail
Medical News - Arthritis and Rheumatology
After 12 weeks of treatment certolizumab pegol (Cimzia ®) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients regardless of whether or not they had received prior TNF inhibitors, concluded the latest analysis of the Phase III b REALISTIC trial...

Read more: Arthritis / Rheumatology News From Medical News Today